Showing results (211-220 of 244) with videos related to
Sort By:
Pageof 25
Movement Disorders : Official Journal of the Movement Disorder Society|December 29, 2023
Peripheral Inflammatory and Immune Landscape in Multiple System Atrophy: A Cross-Sectional StudyXinrong Yuan, Linlin Wan, Zhao Chen, et al.Chemical Communications (Cambridge, England)|April 2, 2026
A dual-additive strategy constructing robust Li3N-Rich SEI and proton scavenging for high-rate lithium metal batteriesDongxiang Li, Suyan Niu, Zhigang Zhang, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 13, 2011
Improving transient elastography performance for detecting hepatitis B cirrhosisYong Peng Chen, Xie Er Liang, Lin Dai, et al.Journal of Gastroenterology and Hepatology|September 15, 2011
(Z)2-(5-(4-methoxybenzylidene)-2, 4-dioxothiazolidin-3-yl) acetic acid protects rats from CCl(4) -induced liver injuryZhen-ling Wang, Chong-yang Deng, Hao Zheng, et al.Mathematical Biosciences and Engineering : MBE|April 3, 2020
A microRNA disease signature associated with lymph node metastasis of lung adenocarcinomaShu Yi Cen, Kai You Fu, Yue Shi, et al.JAMA Psychiatry|May 17, 2023
Effect of an Emergency Department Process Improvement Package on Suicide Prevention: The ED-SAFE 2 Cluster Randomized Clinical TrialEdwin D Boudreaux, Celine Larkin, Ana Vallejo Sefair, et al.Hepatitis Monthly|July 12, 2012
Hepatitis B Virus Genotype B and High Expression of Interferon Alpha Receptor β Subunit are Associated With Better Response to Pegylated Interferon Alpha 2a in Chinese Patients With Chronic Hepatitis B InfectionHe Bin Fan, Ya Bin Guo, You Fu Zhu, et al.Scientific Reports|November 8, 2016
mTOR Overactivation in Mesenchymal cells Aggravates CCl4- Induced liver FibrosisLanlan Shan, Yan Ding, You Fu, et al.Journal of Nanobiotechnology|October 1, 2021
Polydopamine-coated UiO-66 nanoparticles loaded with perfluorotributylamine/tirapazamine for hypoxia-activated osteosarcoma therapyHongfang Chen, You Fu, Kai Feng, et al.Trials|December 28, 2021
Evaluation of efficacy and safety of Qiangzhu-qinggan formula as an adjunctive therapy in adult patients with severe influenza: study protocol for a randomized parallel placebo-controlled double-blind multicenter trialLei Qiu, Xian-Wei Wu, Shao-Yan Zhang, et al.Pageof 25